Harmony Biosciences Holdings (HRMY) EPS (Basic) (2019 - 2026)

Harmony Biosciences Holdings has disclosed EPS (Basic) across 8 years of filings, most recently posting $0.56 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $0.56, down 29.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.53 (down 5.24% YoY), and the FY2025 annual result was $2.76, up 7.81% from the prior year.
• EPS (Basic) came in at $0.56 for Q1 2026 at Harmony Biosciences Holdings, up from $0.4 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $1.48 in Q3 2022 to a low of $0.2 in Q2 2024.
• The 5-year median for EPS (Basic) is $0.64 (2023), against an average of $0.65.
• Across the five-year window, EPS (Basic) jumped 970.59% in 2022 and slumped 64.91% in 2024, its largest moves.
• Harmony Biosciences Holdings' EPS (Basic) stood at $0.82 in 2022, then plunged by 43.9% to $0.46 in 2023, then soared by 89.13% to $0.87 in 2024, then sank by 54.02% to $0.4 in 2025, then surged by 40.0% to $0.56 in 2026.
• The last three EPS (Basic) figures came in at $0.56 (Q1 2026), $0.4 (Q4 2025), and $0.88 (Q3 2025), per Business Quant data.